OXBDF (Oxford BioMedica) Cash per Share: $1.07 (As of Dec. 2025)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Oxford BioMedica PLC OXBDF

72 GF Score

Price $7.99

GF Value $7.16

Valuation Modestly Overvalued

5 Warning Signs

View Full Analysis

What is Oxford BioMedica Cash per Share?

Oxford BioMedica OXBDF 72 Cash per Share is $1.07 as of Dec. 2025. GuruFocus rates OXBDF with a GF Score™ of 72/100 and a GF Value™ of $7.16 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Oxford BioMedica's Cash per Share for the quarter that ended in Dec. 2025 was $1.07.

Oxford BioMedica (OTCPK:OXBDF) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Oxford BioMedica Cash per Share Related Terms

Oxford BioMedica Cash per Share Historical Data

* Premium members only.

The historical data trend for Oxford BioMedica's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford BioMedica Cash per Share Chart

Oxford BioMedica Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Cash per Share

Get a 7-Day Free Trial

1.68

1.79

1.36

0.72

1.07

Oxford BioMedica Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Cash per Share	Get a 7-Day Free Trial															1.36	0.98	0.72	0.69	1.07

72GF Score

Oxford BioMedica PLC OXBDF

Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Oxford BioMedica Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Oxford BioMedica's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	129.697	/	120.8
	=	1.07

Oxford BioMedica's Cash per Share for the quarter that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	129.697	/	120.8
	=	1.07

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of $1.07 mean?

Oxford BioMedica (OXBDF) has a Cash per Share of $1.07 as of Dec. 2025. Cash per share is the per-share value of a company's available cash. View historical data for Oxford BioMedica and its competitors.

Is Oxford BioMedica's Cash per Share too high?

Oxford BioMedica's current Cash per Share is $1.07. Overall, Oxford BioMedica has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Oxford BioMedica's Cash per Share compare to VRTX and REGN?

Oxford BioMedica's Cash per Share of $1.07 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Biotechnology company?

A good Cash per Share depends on the Biotechnology industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Oxford BioMedica and its competitors. Oxford BioMedica's current Cash per Share is $1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Oxford BioMedica stock overvalued right now?

Based on GuruFocus' analysis, Oxford BioMedica (OXBDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $7.16, compared to a current price of $7.99 — trading 11.6% above its estimated fair value. The current Cash per Share is $1.07. Oxford BioMedica's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For Oxford BioMedica (OXBDF), the current Cash per Share is $1.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oxford BioMedica (OXBDF) Overvalued in 2026?

Based on GuruFocus' analysis, Oxford BioMedica stock appears to be overvalued. The current stock price of $7.99 is trading 11.6% above its estimated GF Value™ of $7.16. GuruFocus considers Oxford BioMedica to be Modestly Overvalued.

Key valuation signals for OXBDF:

Cash per Share: $1.07
GF Value™: $7.16 vs. price of $7.99 (11.6% above fair value)
GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the OXBDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oxford BioMedica Business Description

Industry Healthcare Biotechnology

Comparable Companies LSE:AVCT LSE:IBT LSE:ONT LSE:PRTC LSE:SCLP LSE:GNS LSE:BVXP LSE:FARN LSE:4BB LSE:HEMO VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges OXBl:UK OXB:UK OXO:Germany

Address Transport Way, Windrush Court, Oxford, GBR, OX4 6LT

Website https://www.oxb.com

Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus, and other viral vector types. Geographically, it derives maximum revenue from the United States, and the rest from Europe, the UK, and the Rest of the world.

72GF Score

Get the complete analysis for OXBDF

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.99

Price

$7.16

GF Value

View OXBDF Analysis

See Cash per Share data for all stocks →